Cargando…

The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas

BACKGROUND: Results from previous trials suggest that daptomycin may result in faster clinical improvement than penicillinase-resistant penicillins or vancomycin for patients with complicated skin and skin structure infections. OBJECTIVE: The objective was to evaluate whether daptomycin treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pertel, P E, Eisenstein, B I, Link, A S, Donfrid, B, Biermann, E J A, Bernardo, P, Martone, W J
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2009
Materias:	Infection
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705813/ https://www.ncbi.nlm.nih.gov/pubmed/19222623 http://dx.doi.org/10.1111/j.1742-1241.2008.01988.x

Ejemplares similares

Erysipelas or cellulitis with a prosthetic joint in situ
por: Wouthuyzen-Bakker, Marjan, et al.
Publicado: (2018)

Genetic Susceptibility to Non-Necrotizing Erysipelas/Cellulitis
por: Hannula-Jouppi, Katariina, et al.
Publicado: (2013)

From the Cochrane Library: Interventions for Cellulitis and Erysipelas
por: Oganesyan, Ani, et al.
Publicado: (2022)

Low sensitivity of needle aspiration cultures in patients with cellulitis/erysipelas
por: Piso, Rein Jan, et al.
Publicado: (2016)

Evaluation of Antibiotic Treatment on the Duration of Hospitalization of Patients with Erysipelas and Bacterial Cellulitis
por: Kosior, Ewelina, et al.
Publicado: (2018)

673 Comparative Effectiveness of Vancomycin vs Early Daptomycin for MRSA Bacteremia with Vancomycin MIC >1 mg/L: A Multicenter Evaluation
por: Moise, Pamela, et al.
Publicado: (2014)

Retrospective Study of Linezolid vs. Daptomycin for the Treatment of Vancomycin--resistant Enterococcal Bloodstream Infection
por: Rai, Rena, et al.
Publicado: (2017)

Use of daptomycin and vancomycin in blood stream infections with PDR Acinetobacter Baumanii
por: Alexandropoulos, P, et al.
Publicado: (2015)

A Retrospective Study on the Effectiveness and Safety of Vancomycin versus Daptomycin in Hemodialysis Patients
por: Kato, Hideo, et al.
Publicado: (2022)

A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections
por: Chuang, Yu-Chung, et al.
Publicado: (2018)

Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria
por: Blaskovich, Mark A. T., et al.
Publicado: (2018)

1062. Daptomycin/Ceftaroline in Combination vs. Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Fox, Matthew, et al.
Publicado: (2018)

Clinical Outcomes With Definitive Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia With Retained Daptomycin and Ceftaroline Combination Therapy vs De-escalation to Monotherapy With Vancomycin, Daptomycin, or Ceftaroline
por: Nichols, Courtney N, et al.
Publicado: (2021)

1539. Dalbavancin, Vancomycin, and Daptomycin Alone and in Combination with Cefazolin Against Vancomycin Intermediate-Resistant (VISA) and Daptomycin Non-Susceptible (DNS) Staphylococcus aureus
por: Abdul-Mutakabbir, Jacinda, et al.
Publicado: (2019)

Breakthrough daptomycin-, linezolid-, vancomycin-resistant Enterococcus faecium bacteremia during protracted daptomycin therapy: A case report
por: Pincus, Nathan B., et al.
Publicado: (2022)

Comparison of linezolid and daptomycin for the treatment of vancomycin-resistant enterococcal bacteremia
por: Narayanan, Navaneeth, et al.
Publicado: (2019)

Editorial Commentary: Linezolid vs Daptomycin for Vancomycin-Resistant Enterococci: The Evidence Gap Between Trials and Clinical Experience
por: McKinnell, James A., et al.
Publicado: (2015)

Treatment of Clostridium difficile infection in mice with vancomycin alone is as effective as treatment with vancomycin and metronidazole in combination
por: Erikstrup, Lise Tornvig, et al.
Publicado: (2015)

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
por: Estes, Kerry S, et al.
Publicado: (2010)

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
por: Zarogoulidis, Paul, et al.
Publicado: (2014)

High Yield of Blood Cultures in the Etiologic Diagnosis of Cellulitis, Erysipelas, and Cutaneous Abscess in Elderly Patients
por: Taniguchi, Tomohiro, et al.
Publicado: (2022)

Vancomycin elution from a biphasic ceramic bone substitute
por: Stravinskas, M., et al.
Publicado: (2019)

On Erysipelas
por: Blackett, P. C.
Publicado: (1826)

Observation of “Seesaw Effect” with Vancomycin, Teicoplanin, Daptomycin and Ceftaroline in 150 Unique MRSA Strains
por: Barber, Katie E., et al.
Publicado: (2014)

New Mutations in cls Lead to Daptomycin Resistance in a Clinical Vancomycin- and Daptomycin-Resistant Enterococcus faecium Strain
por: Li, Weiwei, et al.
Publicado: (2022)

Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates
por: Rehm, Susan J., et al.
Publicado: (2008)

Comparing the Outcomes of Ceftaroline plus Vancomycin or Daptomycin Combination Therapy versus Vancomycin or Daptomycin Monotherapy in Adults with Methicillin-Resistant Staphylococcus aureus Bacteremia—A Meta-Analysis
por: Huang, Chienhsiu, et al.
Publicado: (2022)

Erysipelas
por: Young, A. A.
Publicado: (1900)

Erysipelas
por: Allen, J. H.
Publicado: (1893)

In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci
por: Tong, Jiepeng, et al.
Publicado: (2021)

Effectiveness of Daptomycin in Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Despite Vancomycin
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2017)

Treatment of osteomyelitis defects by a vancomycin-loaded gelatin/β-tricalcium phosphate composite scaffold
por: Zhou, J., et al.
Publicado: (2018)

Risk Factors and Outcomes Associated With Acquisition of Daptomycin and Linezolid–Nonsusceptible Vancomycin-Resistant Enterococcus
por: Greene, Matthew H, et al.
Publicado: (2018)

Efficacy and safety of intrawound vancomycin in primary hip and knee arthroplasty: a systematic review and meta-analysis: implications for the design of a randomized controlled trial
por: Xu, Hong, et al.
Publicado: (2020)

Outpatient parenteral antibiotic therapy with daptomycin: insights from a patient registry
por: Martone, W J, et al.
Publicado: (2008)

Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs
por: Crompton, Jason A., et al.
Publicado: (2010)

Kreosote in Erysipelas
por: Fahnestock, P.
Publicado: (1849)

1045 Linezolid Compared to Daptomycin for the Treatment of Vancomycin-resistant Enterococcal Urinary Tract Infections
por: Moenster, Ryan P., et al.
Publicado: (2014)

Effect of daptomycin and vancomycin on Staphylococcus epidermidis biofilms: An in vitro assessment using fluorescence in situ hybridization
por: Sutrave, S., et al.
Publicado: (2019)

Vancomycin and daptomycin dosing recommendations in patients receiving home hemodialysis using Monte Carlo simulation
por: Lewis, Susan J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_61rkgl33ho3fc5dqocu05btjs5